5 hrs ago
Regeneron Announces Upcoming 2013 Investor Conference Presentation
Regeneron Pharmaceuticals, Inc. will webcast its presentation at the Oppenheimer 24 Annual Healthcare Conference on Wednesday, December 11, 2013.
9 hrs ago
Medgenics to Present at the Oppenheimer 24th Annual Healthcare Conference
MISGAV, Israel & SAN FRANCISCO -- -- Medgenics, Inc. , the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that Company management will participate in the Oppenheimer 24th Annual Healthcare Conference taking place from December 10-11, 2013 in New York ... (more)
13 hrs ago
HMS Holdings Corp. To Present at Oppenheimer 24th Annual Healthcare Conference
HMS Holdings Corp. today announced that it will be presenting at the Oppenheimer 24th Annual Healthcare Conference, which will take place December 10-11, 2013 at Crowne Plaza Hotel in New York.
Tue Dec 03, 2013
StoneCastle Financial Corp. Announces Partial Exercise of Overallotment Option
NEW YORK, Dec. 3, 2013 -- StoneCastle Financial Corp. today announced that the underwriters of its initial public offering exercised a portion of their overallotment option and purchased an additional 125,000 shares of common stock, to be sold at $25 per share.
Mon Dec 02, 2013
Cempra, Inc. to Present at Piper Jaffray 25th Annual Healthcare...
Cempra, Inc. today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at the Piper Jaffray 25th Annual Healthcare Conference at 2:30 p.m. EST, Wednesday, Dec. 4, at The New York Palace Hotel, and at the Oppenheimer 24th Annual Healthcare Conference at 3:55 p.m. EST, Wednesday, Dec. 11, at The Crowne Plaza ... (more)
America First Multifamily Investors, L.P. Announces Closing of...
America First Multifamily Investors, L.P. announced today the closing of its previously announced underwritten public offering of 7,200,000 shares representing assigned limited partnership interests at $6.25 per share.
SciClone to Present at Oppenheimer Healthcare Conference on December 10, 2013
SciClone Pharmaceuticals, Inc. today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10, 2013, at 3:20 pm ET at the Crowne Plaza Hotel in New York.
Mon Nov 25, 2013
America First Multifamily Investors, L.P. Announces Public Offering...
America First Multifamily Investors, L.P. today announced that it has commenced an underwritten public offering of 6,000,000 shares representing assigned limited partnership interests of the Company.
Incyte to Present at the Oppenheimer 24th Annual Healthcare Conference
Incyte Corporation announced today it will present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11 at 10:40 a.m. in New York.
Sat Nov 23, 2013
The sexism of 'Bunga Bunga' bank boys drove me to despair. And it's...
Everyone knows the City is one of the toughest environments to work in. It's no place for shrinking violets.
Fri Nov 22, 2013
Huntington Leads Banks as Stocks Stay Hot
The broad indices were all strong, with the Dow Jones Industrial Average was up 0.7% to 67.69, with all but two of the 24 index components ending with gains.
IPO Report: 500.com
Nine other operating companies scheduled IPOs for this week.. The full IPO calendar can be found at IPOpremium .
Thu Nov 21, 2013
Customer Interaction Solutions
IPO Report: Sungy Mobile
Sungy Mobile is a leading provider of mobile internet products and services globally with a focus on applications and mobile platform development.
The Times of Israel
Israeli agritech IPO could be first of a controversial wave
President Shimon Peres examines some of Evogene's experimental plants on a visit to the company's headquarters last July As IPOs go, the $86 million public offering that Israel's Evogene presented to US investors Thursday wasn't particularly big, but it could be the beginning of the next big trend, according to experts.
Wed Nov 20, 2013
BioCryst to Present at Two Upcoming Investor Conferences
BioCryst Pharmaceuticals designs, optimizes and develops novel small molecule drugs that block key enzymes involved in infectious and inflammatory diseases, with the goal of addressing unmet medical needs of patients and physicians.
Analysts' Actions: Ba DKS CHRW Hpy PNR
Valuation call, as the stock is trading at a price-to-earnings ratio of 14, based on expected 2016 earnings, Oppenheimer said.
Mon Nov 18, 2013
New Haven Independent
Zen Sex-Abuse "Single" Kindles An E-Revolution
Mark Oppenheimer had an old story to tell - and found a new way to tell it. Then he spoke about it.
Thu Nov 14, 2013
ND/NFa s a The Act of Killinga Wins 2013 Puma Impact Award image
The Act of Killing director Joshua Oppenheimer with Producer Signe Byrge Sorensen , Christine Cynn, co-director and Jess Search, Chief Executive, BRITDOC.
Wed Nov 13, 2013
StoneCastle Financial Corp. Closes on $110M Initial Public Offering
NEW YORK, Nov. 13, 2013 -- StoneCastle Financial Corp. completed its previously announced initial public offering of 4,400,000 shares of its common stock at a price of $25.00 per share on November 13, 2013.
Sat Nov 09, 2013
Crain's New York Business
Faculty Row site helps professors survive in free-agent economy
When former Hunter College biology professor Jason Dictenberg recently began looking for work to supplement his endeavors at his Manhattan biotech startup, he turned to Faculty Row.